Chester County News and Community Website
MALVERN, PA — TELA Bio, Inc. (NASDAQ: TELA) announced that two studies examining clinical outcomes with the use of its OviTex Reinforced Tissue Matrix will be presented at the 2022 …
TELA Bio Highlights Results from BRAVO and ReBAR Studies on the Benefits of OviTex Read More MALVERN, PA — TELA Bio, Inc. (NASDAQ: TELA) announced the recent publication of the 12-month analysis from the BRAVO Study in the Journal of Clinical Medicine.
TELA Bio Announces Publication of 12-Month Results from the BRAVO Study Read More MALVERN, PA — TELA Bio, Inc. (NASDAQ: TELA) announced details of the clinical research presented last week at the Society of American Gastrointestinal and Endoscopic Surgeons (SAGES) meeting in Las …
TELA Bio Announces New Data on Use of OviTex in a Range of Hernia Repair Applications Read More MALVERN, PA — TELA Bio, Inc. (NASDAQ: TELA) announced three upcoming poster presentations on its OviTex Reinforced Tissue Matrix portfolio. Data demonstrating the effectiveness of OviTex in a variety of …
TELA Bio’s OviTex Reinforced Tissue Matrix to be Featured in Three Presentations at SAGES 2021 Read More MALVERN, PA — TELA Bio, Inc. (NASDAQ: TELA) has announced the first use of its OviTex LPR Reinforced Tissue Matrix in Europe.
NHS Surgeon First in Europe to Implant TELA Bio’s OviTex LPR Reinforced Tissue Matrix Read More